Search by Drug Name or NDC

    NDC 68001-0468-37 Oxaliplatin 5 mg/mL Details

    Oxaliplatin 5 mg/mL

    Oxaliplatin is a INTRAVENOUS INJECTION, SOLUTION in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by BluePoint Laboratories. The primary component is OXALIPLATIN.

    Product Information

    NDC 68001-0468
    Product ID 68001-468_091ba34a-a181-7f31-e063-6294a90a92b6
    Associated GPIs 21100028002025 21100028002030
    GCN Sequence Number 059162
    GCN Sequence Number Description oxaliplatin VIAL 50 MG/10ML INTRAVEN
    HIC3 V1A
    HIC3 Description ANTINEOPLASTIC - ALKYLATING AGENTS
    GCN 24699
    HICL Sequence Number 016687
    HICL Sequence Number Description OXALIPLATIN
    Brand/Generic Generic
    Proprietary Name Oxaliplatin
    Proprietary Name Suffix n/a
    Non-Proprietary Name Oxaliplatin
    Product Type HUMAN PRESCRIPTION DRUG
    Dosage Form INJECTION, SOLUTION
    Route INTRAVENOUS
    Active Ingredient Strength 5
    Active Ingredient Units mg/mL
    Substance Name OXALIPLATIN
    Labeler Name BluePoint Laboratories
    Pharmaceutical Class Platinum-based Drug [EPC], Platinum-containing Compounds [EXT]
    DEA Schedule n/a
    Marketing Category ANDA
    Application Number ANDA204368
    Listing Certified Through 2024-12-31

    Package

    NDC 68001-0468-37 (68001046837)

    NDC Package Code 68001-468-37
    Billing NDC 68001046837
    Package 1 VIAL in 1 CARTON (68001-468-37) / 20 mL in 1 VIAL
    Marketing Start Date 2020-12-09
    NDC Exclude Flag N
    Pricing Information N/A